The risk of liver fibrosis was found to increase as the severity of metabolic abnormal fatty liver disease increased.
Kangbuk Samsung Hospital Gastroenterology Prof. Cho Yong-gyun, Sohn Won, and radiology professor Kwon Heon-ju, who visited the hospital’s comprehensive health check-up center between 2015 and 2018 Liver fibrosis was measured.
According to the research team, metabolic abnormal fatty liver disease is a new concept that judges only whether it is accompanied by metabolic abnormalities such as obesity, hyperlipidemia, high blood pressure, and diabetes, regardless of the cause of liver disease.
Regardless of the cause of liver disease, such as viral hepatitis or alcohol, the research team analyzed the presence and severity of metabolic diseases, including ▲ overweight group ▲ obese group ▲ group with normal weight but two or more metabolic diseases ▲ metabolism including type 2 diabetes They were divided into groups with the disease and compared.
As a result, the risk of liver fibrosis was ▲1.3% in the overweight group ▲5.5% in the obese group ▲6.4% in the group with normal weight but two metabolic diseases ▲18.9% in the group with metabolic diseases including type 2 diabetes appear.
In particular, the research team explained that the risk of liver fibrosis increases as a person has more factors of metabolic diseases such as abnormal waist circumference, abnormal blood pressure, hyperlipidemia, and obesity. .
Professor Sohn said, “This is a study that analyzed and verified the risk of liver fibrosis in Asian patients with metabolic abnormality fatty liver disease.
Meanwhile, this study was published in the May issue of ‘Clinical Gastroenterology and Hepatology’, an academic journal in the digestive tract.
